Published in Semin Perinatol on December 01, 2004
Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10
Oligodendrocyte-encoded HIF function couples postnatal myelination and white matter angiogenesis. Cell (2014) 1.83
The Nogo receptor NgR1 mediates infection by mammalian reovirus. Cell Host Microbe (2014) 1.56
Sprouting, regeneration and circuit formation in the injured spinal cord: factors and activity. Philos Trans R Soc Lond B Biol Sci (2006) 1.48
Cell replacement therapy in neurological disease. Philos Trans R Soc Lond B Biol Sci (2006) 1.29
Hypoxic injury during neonatal development in murine brain: correlation between in vivo DTI findings and behavioral assessment. Cereb Cortex (2009) 1.00
Aquaporin 1 - a novel player in spinal cord injury. J Neurochem (2008) 0.96
Current concept in neural regeneration research: NSCs isolation, characterization and transplantation in various neurodegenerative diseases and stroke: A review. J Adv Res (2013) 0.88
Neonatal tissue damage facilitates nociceptive synaptic input to the developing superficial dorsal horn via NGF-dependent mechanisms. Pain (2011) 0.85
Targeting a dominant negative rho kinase to neurons promotes axonal outgrowth and partial functional recovery after rat rubrospinal tract lesion. Mol Ther (2009) 0.84
Short and long-term analysis and comparison of neurodegeneration and inflammatory cell response in the ipsilateral and contralateral hemisphere of the neonatal mouse brain after hypoxia/ischemia. Neurol Res Int (2012) 0.83
Novel implications of Lingo-1 and its signaling partners in schizophrenia. Transl Psychiatry (2014) 0.82
Oligodendrocytes as regulators of neuronal networks during early postnatal development. PLoS One (2011) 0.82
Persistent changes in peripheral and spinal nociceptive processing after early tissue injury. Exp Neurol (2015) 0.81
Expression of a dominant-negative Rho-kinase promotes neurite outgrowth in a microenvironment mimicking injured central nervous system. Acta Pharmacol Sin (2010) 0.79
Genetic variants in Nogo receptor signaling pathways may be associated with early life adversity in schizophrenia susceptibility. BBA Clin (2014) 0.75
Classic and Golli Myelin Basic Protein have distinct developmental trajectories in human visual cortex. Front Neurosci (2015) 0.75
Developmental pattern changes of prefrontal efferents in the juvenile gerbil (Meriones unguiculatus). J Neural Transm (Vienna) (2007) 0.75
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 6.99
Axon regeneration in young adult mice lacking Nogo-A/B. Neuron (2003) 4.23
Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science (2005) 4.15
Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science (2002) 3.50
Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron (2010) 3.44
Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci (2010) 3.36
An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron (2009) 3.34
Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature (2002) 3.33
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci (2012) 2.92
Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci (2003) 2.76
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron (2004) 2.76
Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci (2004) 2.67
A new role for Nogo as a regulator of vascular remodeling. Nat Med (2004) 2.63
Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29
Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci (2006) 2.28
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol (2004) 2.14
The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci (2003) 2.11
Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10
Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci (2002) 2.01
Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci (2002) 1.96
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96
Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci (2007) 1.88
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron (2013) 1.87
MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci (2010) 1.86
Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J (2003) 1.78
The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci (2006) 1.77
Neogenin mediates the action of repulsive guidance molecule. Nat Cell Biol (2004) 1.77
Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci (2008) 1.66
Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci (2010) 1.66
Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci (2007) 1.64
The reticulons: a family of proteins with diverse functions. Genome Biol (2007) 1.62
Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci (2002) 1.55
Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci (2003) 1.52
Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol (2006) 1.44
The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol (2007) 1.43
Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci (2005) 1.43
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A (2010) 1.42
Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci U S A (2006) 1.39
ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist (2007) 1.38
The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci (2008) 1.38
Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ (2009) 1.37
LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci (2009) 1.32
Structural bases for CRMP function in plexin-dependent semaphorin3A signaling. EMBO J (2003) 1.29
Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke (2010) 1.25
Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov (2003) 1.25
RanBPM contributes to Semaphorin3A signaling through plexin-A receptors. J Neurosci (2006) 1.24
Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci (2006) 1.24
Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci (2009) 1.22
Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol (2011) 1.18
Anatomical plasticity of adult brain is titrated by Nogo Receptor 1. Neuron (2013) 1.18
Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci (2006) 1.16
Response to correspondence: Kim et al., "axon regeneration in young adult mice lacking Nogo-A/B." Neuron 38, 187-199. Neuron (2007) 1.15
Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci (2011) 1.14
Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J Neurosci (2005) 1.12
Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol (2011) 1.12
Release of MICAL autoinhibition by semaphorin-plexin signaling promotes interaction with collapsin response mediator protein. J Neurosci (2008) 1.12
Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis. J Neurosci (2009) 1.11
Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. J Biol Chem (2006) 1.07
Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma (2009) 1.03
Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science (2011) 1.03
Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc Natl Acad Sci U S A (2012) 1.02
Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J Neurosci (2012) 1.02
Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma (2010) 1.00
Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J Mol Med (Berl) (2009) 0.99
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain (2012) 0.98
Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci (2005) 0.98
Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease. Prion (2012) 0.97
A multi-domain fragment of Nogo-A protein is a potent inhibitor of cortical axon regeneration via Nogo receptor 1. J Biol Chem (2011) 0.97
Nogo and the Nogo-66 receptor. Prog Brain Res (2002) 0.97
Cellular prion protein mediates the toxicity of beta-amyloid oligomers: implications for Alzheimer disease. Arch Neurol (2009) 0.96
Axonal regeneration induced by blockade of glial inhibitors coupled with activation of intrinsic neuronal growth pathways. Exp Neurol (2012) 0.96
Selective temporal and regional alterations of Nogo-A and small proline-rich repeat protein 1A (SPRR1A) but not Nogo-66 receptor (NgR) occur following traumatic brain injury in the rat. Exp Neurol (2006) 0.95
Nogo-C is sufficient to delay nerve regeneration. Mol Cell Neurosci (2003) 0.94
PlexinA2 limits recovery from corticospinal axotomy by mediating oligodendrocyte-derived Sema6A growth inhibition. Mol Cell Neurosci (2012) 0.92
Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage. J Biol Chem (2011) 0.91
A neutralizing anti-Nogo66 receptor monoclonal antibody reverses inhibition of neurite outgrowth by central nervous system myelin. J Biol Chem (2004) 0.90
Regenerating nerves follow the road more traveled. Nat Neurosci (2002) 0.90
Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice. Curr Alzheimer Res (2007) 0.89
Diffusion tensor imaging as a predictor of locomotor function after experimental spinal cord injury and recovery. J Neurotrauma (2014) 0.87
Nogo receptor deletion and multimodal exercise improve distinct aspects of recovery in cervical spinal cord injury. J Neurotrauma (2010) 0.86
Differential but competitive binding of Nogo protein and class i major histocompatibility complex (MHCI) to the PIR-B ectodomain provides an inhibition of cells. J Biol Chem (2011) 0.86
Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion. J Neurotrauma (2014) 0.83
Functional MRI and other non-invasive imaging technologies: providing visual biomarkers for spinal cord structure and function after injury. Exp Neurol (2008) 0.81
Neuroscience. Lynx for braking plasticity. Science (2010) 0.78
Multimodal exercises simultaneously stimulating cortical and brainstem pathways after unilateral corticospinal lesion. Brain Res (2013) 0.77
Delayed amyloid plaque deposition and behavioral deficits in outcrossed AβPP/PS1 mice. J Comp Neurol (2013) 0.77
No association between schizophrenia and polymorphisms of the PlexinA2 gene in Chinese Han Trios. Schizophr Res (2007) 0.76
Nogo-A marks motor neuron disease. Ann Neurol (2007) 0.76
Serum Nogo-A levels are not elevated in amyotrophic lateral sclerosis patients. Biomarkers (2009) 0.75